
Monoact 500mg/500mg Injection
Marketer
Active Healthcare
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Monoact 500mg/500mg Injection
Combiflox 500mg/500mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be under a physician's direct guidance; strict adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, edema, dyspnea). Inform your doctor about all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration promote recovery. Your doctor may order lab tests and imaging to monitor therapeutic response.
Uses of Monoact 500mg/500mg Injection
Managing bacterial illnesses
Major Benefits of Monoact 500mg/500mg Injection:
Administering this medication will be done by your physician or their qualified assistant; please do not attempt self-medication.
Common Side effects of Monoact 500mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Monoact 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Monoact 500mg/500mg Injection works:
Cefoperazone and Sulbactam 500mg/500mg (Monoact Injection) combine the antibiotic Cefoperazone with the beta-lactamase inhibitor Sulbactam. Cefoperazone's antibacterial action disrupts bacterial cell wall synthesis, hindering their survival. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Monoact 500mg/500mg Injection treatment can trigger adverse reactions including facial flushing, tachycardia, nausea, increased thirst, chest discomfort, and hypotension (a disulfiram-like effect).
PregnancySAFE IF PRESCRIBED
The injectable medication Monoact 500mg/500mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Monoact 500mg/500mg Injection is considered safe while breastfeeding. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Monoact 500mg/500mg Injection's impact on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Monoact 500mg/500mg Injection's use in individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data on Monoact 500mg/500mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Monoact 500mg/500mg Injection :
Omit a Monoact 500mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Monoact 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
